ACHIEVEMENT OF LOW DISEASE ACTIVITY IN PATIENTS INITIATING INFLIXIMAB WITH AND WITHOUT DOSE ESCALATION

被引：0

作者：

Cohen, S. ^{[1
]}

Reed, G. ^{[2
]}

Magner, R. ^{[3
]}

Kafka, S. ^{[4
]}

Ellis, L. ^{[4
]}

DeHoratius, R. J. ^{[5
]}

Greenberg, J. D. ^{[6
]}

机构：

[1] Metroplex Clin Res Ctr, Dallas, TX USA

[2] LLC Mass Med Sch, Corrona, Southborough, MA USA

[3] U Mass Med Sch, Worcester, MA USA

[4] Janssen Sci Affairs LLC, Horsham, PA USA

[5] Horsham Phila, LLC Kimmel Sch Med, Janssen Sci Affairs, Horsham, PA USA

[6] NYU, LLC, Sch Med, Corrona, Southborough, NY USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.2771

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0156

引用

页码：238 / 239

页数：2

共 50 条

[31] ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB [J].

Kappelman, Michael ;

Wohl, David A. ;

Herfarth, Hans ;

Firestine, Ann M. ;

Adler, Jeremy ;

Steiner, Steven J. ;

Colletti, Richard B. ;

Park, K. T. ;

Grossman, Andrew B. ;

Ivanova, Anastasia ;

Galanko, Joseph ;

Osaba, Lourdes ;

Chun, Kelly Y. ;

Weinberger, Morris ;

Margolis, Peter ;

Saeed, Shehzad ;

Bousvaros, Athos .

GASTROENTEROLOGY, 2023, 164 (06) :S168-S169

[32] Low dose of infliximab is inadequate in most patients with spondylarthropathies [J].

Sidiropoulos, P ;

Kritikos, HD ;

Siakka, P ;

Mamoulaki, M ;

Kouroumali, H ;

Voudouris, K ;

Boumpas, DT .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) :513-516

[33] COMPARISON OF DOSE ESCALATION OF INFLIXIMAB AND THE ADDITION OF TACROLIMUS IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO INFLIXIMAB AND METHOTREXATE COMBINATION THERAPY [J].

Yonemoto, Y. ;

Okamura, K. ;

Kaneko, T. ;

Kobayashi, T. ;

Takagishi, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 :199-200

[34] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE [J].

Nichols, Patrick ;

Kozlicki, Miranda ;

Fann, Jessica ;

Zuckerman, Autumn ;

Dalal, Robin .

INFLAMMATORY BOWEL DISEASES, 2024, 30 :S88-S89

[35] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE [J].

Nichols, Patrick ;

Kozlicki, Miranda ;

Fann, Jessica ;

Zuckerman, Autumn ;

Dalal, Robin .

GASTROENTEROLOGY, 2024, 166 (03) :S123-S123

[36] Risankizumab dose escalation in patients with Crohn's disease [J].

Zuckerman, Autumn ;

Nichols, Patrick ;

Fann, Jessica ;

Kozlicki, Miranda ;

Dalal, Robin .

CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 :S8-S9

[37] Infliximab dose intensification in patients with Crohn's disease [J].

Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (11) :588-589

[38] Efficacy, Safety, and Pharmacokinetics of Infliximab Dose Escalation in Pediatric Patients With Crohn's Disease or Ulcerative Colitis: An Analysis of the DEVELOP Registry [J].

Dubinsky, Marla C. ;

Markowitz, James ;

Busse, Christopher ;

Koletzko, Sibylle ;

Winter, Harland ;

Baldassano, Robert ;

Colletti, Richard ;

Kugathasan, Subra ;

Ruemmele, Frank ;

Griffiths, Anne ;

Gasink, Christopher ;

Adedokun, Omoniyi ;

Izanec, James L. ;

Gao, Long-Long ;

Ma, Tony ;

Ott, Elyssa ;

Hyams, Jeffrey .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 :S592-S593

[39] Previous Non-Response to Infliximab Predicts Early Dose-Escalation in Adalimumab Treated Crohn's Disease Patients [J].

Bultman, Evelien ;

West, Rachel L. ;

van Liere-Baron, Astrid ;

Kuipers, Ernst J. ;

Zelinkova, Zuzana ;

Woude, Janneke V. .

GASTROENTEROLOGY, 2010, 138 (05) :S701-S702

[40] Comparative outcomes of Adalimumab and Infliximab dose escalation in Inflammatory Bowel Disease patients failing first-line biologic treatment [J].

Atay, A. ;

Cagir, Y. ;

Ergul, M. ;

Ozturk, O. ;

Durak, M. B. ;

Yuksel, I .

JOURNAL OF CROHNS & COLITIS, 2025, 19 :i1775-i1775

← 1 2 3 4 5 →